Analysed GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) News Sources
GenScript and Tamarind Bio Partner to Connect AI Molecular Design with Rapid Lab Validation
05-08-2026
yahoo.com
Genscript Biotech Corp (GNNSF) (H1 2026) Earnings Call Highlights: Revenue Surges 27.3% to $404. ...
17-08-2026
yahoo.com
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
18-08-2026
yahoo.com
ProBio and Kun Tuo Announce Strategic Collaboration to Deliver Integrated CDMO-CRO Solutions for Advanced Therapies
16-09-2026
yahoo.com
DNA Synthesis Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Integrated DNA Technologies, GenScript Biotech, and Twist Bioscience
18-09-2026
yahoo.com
Global DNA Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $23.1 Billion as Gene Therapy and Synthetic Biology Drive 17.8% CAGR
29-09-2026
yahoo.com
Recombinant Proteins Market - Global Strategic Business Report: Sales Hit to $5.8 Billion by 2030 - Benchmark Thermo Fisher Scientific, Merck KGaA, Amgen, Bio-Techne and GenScript Biotech Amid Tariff Disruption
30-09-2026
yahoo.com
GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation
08-10-2026
yahoo.com
What is the current price of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)?
The current price of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) is $4.5.
GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) since the previous trading day is $0.25.
GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) since the previous trading day is 5.8824%.
What is the most recent average sentiment score for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)?
The most recent average sentiment score for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) is 84 out of 100.
What is the most recent average sentiment for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)?
The most recent sentiment for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) is .
SEC-8K** Filing Available For GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.